Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAFB |
| Upstream (Parents) |
|---|
| (<<) NPL → MAFB |
| (<<) HCLS1 → MAFB |
| (<<) CD14 → MAFB |
| (<<) MS4A6A → MAFB |
| (<<) MS4A4A → MAFB |
| Downstream (Children) |
|---|
| MAFB → ATP1B2 (>>) |
| MAFB → CSF1R (>>) |
| MAFB → CD72 (>>) |
| MAFB → NAIP (>>) |
| MAFB → JAM2 (>>) |
| MAFB → CTSL1 (>>) |
| MAFB → NPL (>>) |
| MAFB → MRM1 (>>) |
| MAFB → FABP4 (>>) |
| MAFB → CD36 (>>) |
| MAFB → FAM124B (>>) |
| MAFB → CECR1 (>>) |
| MAFB → CMKLR1 (>>) |
| MAFB → CPM (>>) |
| MAFB → FAM49A (>>) |
| MAFB → FMO2 (>>) |
| MAFB → MS4A4A (>>) |
| MAFB → PCDH12 (>>) |
| MAFB → CXorf21 (>>) |
| MAFB → TNFSF8 (>>) |
| MAFB → FLI1 (>>) |
| MAFB → CCDC88A (>>) |
| MAFB → TLR1 (>>) |
